Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence
Year: 2017
Type: review
Abstract: Blacks are two to three times as likely as whites to die of preventable heart disease and stroke. Declines in mortality from heart disease have not eliminated racial disparities. Control and effective treatment of hypertension, a leading cause of cardiovascular disease, among blacks is less than in whites and remains a challenge. One of the driving forces behind this racial/ethnic disparity is medication nonadherence whose cause is embedded in social determinants. Eight practical approaches to addressing medication adherence with the potential to attenuate disparities were identified and include: (1) patient engagement strategies, (2) consumer-directed health care, (3) patient portals, (4) smart apps and text messages, (5) digital pillboxes, (6) pharmacist-led engagement, (7) cardiac rehabilitation, and (8) cognitive-based behavior. However, while data suggest that these strategies may improve medication adherence, the effect on ameliorating racial/ethnic disparities is not certain. This review describes the relationship between disparities and medication adherence, which likely plays a role in persistent disparities in cardiovascular morbidity and mortality.
Source: Journal of Clinical Hypertension
DOI: 10.1111/jch.13089
Authors: Keith C. Ferdinand, Kapil Yadav, Samar A. Nasser, Helene D. Clayton‐Jeter, John Lewin, Dennis R. Cryer, Fortunato Fred Senatore
Language: English
Subfield: Family Practice
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,000
Funder: National Institutes of Health
Award: G3050811832
OpenAlex ID: W2753828872
